182 related articles for article (PubMed ID: 15342619)
21. Droperidol and ondansetron-induced QT interval prolongation: a clinical drug interaction study.
Charbit B; Alvarez JC; Dasque E; Abe E; Démolis JL; Funck-Brentano C
Anesthesiology; 2008 Aug; 109(2):206-12. PubMed ID: 18648229
[TBL] [Abstract][Full Text] [Related]
22. Halothane-anaesthetized, closed-chest, guinea-pig model for assessment of drug-induced QT-interval prolongation.
Sakaguchi Y; Takahara A; Nakamura Y; Akie Y; Sugiyama A
Basic Clin Pharmacol Toxicol; 2009 Jan; 104(1):43-8. PubMed ID: 18699795
[TBL] [Abstract][Full Text] [Related]
23. Assessment of drug-induced QT interval prolongation in conscious rabbits.
Kijtawornrat A; Ozkanlar Y; Keene BW; Roche BM; Hamlin DM; Hamlin RL
J Pharmacol Toxicol Methods; 2006; 53(2):168-73. PubMed ID: 16290300
[TBL] [Abstract][Full Text] [Related]
24. Drug-induced long QT and torsade de pointes: recent advances.
Kannankeril PJ; Roden DM
Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043
[TBL] [Abstract][Full Text] [Related]
25. [QTc prolongation induced by intravenous sedation with Haloperidol, Prothipendyl and Lorazepam].
Scharfetter J; Fischer P
Neuropsychiatr; 2014; 28(1):1-5. PubMed ID: 24504742
[TBL] [Abstract][Full Text] [Related]
26. Beat-to-beat variability of QT intervals is increased in patients with drug-induced long-QT syndrome: a case control pilot study.
Hinterseer M; Thomsen MB; Beckmann BM; Pfeufer A; Schimpf R; Wichmann HE; Steinbeck G; Vos MA; Kaab S
Eur Heart J; 2008 Jan; 29(2):185-90. PubMed ID: 18156612
[TBL] [Abstract][Full Text] [Related]
27. The association between intravenous haloperidol and prolonged QT interval.
Hatta K; Takahashi T; Nakamura H; Yamashiro H; Asukai N; Matsuzaki I; Yonezawa Y
J Clin Psychopharmacol; 2001 Jun; 21(3):257-61. PubMed ID: 11386487
[TBL] [Abstract][Full Text] [Related]
28. QT interval prolongation, torsade de pointes and renal disease.
Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
[TBL] [Abstract][Full Text] [Related]
29. Excellent review of psychotropic drug-induced torsade de pointes.
Vieweg WV
Acta Psychiatr Scand; 2005 Jul; 112(1):78; author reply 78-9. PubMed ID: 15952952
[No Abstract] [Full Text] [Related]
30. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
31. Heart rate dependent modification of the QTc cut-off values can improve accurate evaluation of QT prolongation.
Sadanaga T; Sadanaga F; Yao H; Fujishima M
Am J Cardiol; 2004 Mar; 93(6):772-5. PubMed ID: 15019891
[TBL] [Abstract][Full Text] [Related]
32. Influence of promethazine on cardiac repolarisation: a double-blind, midazolam-controlled study.
Owczuk R; Twardowski P; Dylczyk-Sommer A; Wujtewicz MA; Sawicka W; Drogoszewska B; Wujtewicz M
Anaesthesia; 2009 Jun; 64(6):609-14. PubMed ID: 19453313
[TBL] [Abstract][Full Text] [Related]
33. The heart rate-corrected QT interval of conscious beagle dogs: a formula based on analysis of covariance.
Spence S; Soper K; Hoe CM; Coleman J
Toxicol Sci; 1998 Oct; 45(2):247-58. PubMed ID: 9848132
[TBL] [Abstract][Full Text] [Related]
34. QTc abnormalities in deliberate self-poisoning with moclobemide.
Downes MA; Whyte IM; Isbister GK
Intern Med J; 2005 Jul; 35(7):388-91. PubMed ID: 15958107
[TBL] [Abstract][Full Text] [Related]
35. QT interval correction in patients with cirrhosis.
Zambruni A; Di Micoli A; Lubisco A; Domenicali M; Trevisani F; Bernardi M
J Cardiovasc Electrophysiol; 2007 Jan; 18(1):77-82. PubMed ID: 17229304
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6.
Desai M; Tanus-Santos JE; Li L; Gorski JC; Arefayene M; Liu Y; Desta Z; Flockhart DA
Pharmacogenomics J; 2003; 3(2):105-13. PubMed ID: 12746736
[TBL] [Abstract][Full Text] [Related]
37. QT prolongation in guinea pigs for preliminary screening of torsadogenicity of drugs and drug-candidates. II.
Testai L; Breschi MC; Martinotti E; Calderone V
J Appl Toxicol; 2007; 27(3):270-5. PubMed ID: 17265420
[TBL] [Abstract][Full Text] [Related]
38. Sympathomimetic infusion and cardiac repolarization: the normative effects of epinephrine and isoproterenol in healthy subjects.
Magnano AR; Talathoti N; Hallur R; Bloomfield DM; Garan H
J Cardiovasc Electrophysiol; 2006 Sep; 17(9):983-9. PubMed ID: 16879629
[TBL] [Abstract][Full Text] [Related]
39. A maximum likelihood approach for estimating the QT correction factor using mixed effects model.
Shah A; Hajian G
Stat Med; 2003 Jun; 22(11):1901-9. PubMed ID: 12754723
[TBL] [Abstract][Full Text] [Related]
40. Influence of intravenous administration of the antipsychotic drug benperidol on the QT interval.
Schmidt A; Fischer P; Wally B; Scharfetter J
Neuropsychiatr; 2017 Dec; 31(4):172-175. PubMed ID: 28791627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
